Alivecor said that the US authorities have decided not to overturn the Apple Watch import ban made by ITC

AliveCor said on Tuesday that the Biden government had decided not to overturn the import ban on Apple Apple Watch issued by the United States International Trade Commission (ITC).

AliveCor spokesman told Reuters that the Office of the U.S. Trade Representative told the company that it would not overturn the previous decision made by ITC. However, Apple and AliveCor will continue to litigate around the infringement dispute, so they will continue to shelve the previous order of ITC to ban the sale of Apple Watch.

ITC made a ruling in December last year, finding that Apple's technology patent used in Apple Watch infringed AliveCor's patent, and made a decision to ban the import of Apple Watch. Only because the two companies launched a lawsuit around patents, the relevant injunctions were suspended during the lawsuit. The United States Patent and Trademark Office ruled that these patents were invalid earlier that month, and AliveCor has said that it will appeal.
Apple said on Tuesday that it would appeal the import ban decision of the United States International Trade Commission, saying that the decision would have a negative impact on public health.

The White House representative did not immediately respond to the request for comment on Tuesday. The Office of the Trade Representative and the United States International Trade Commission did not comment. The White House will decide whether to overturn the ITC ruling on December 22 based on policy issues within the next 60 days.

IT Home with incident related reports:
AliveCor last year accused Apple of violating three patents related to its KardiaBand, an Apple Watch accessory that can monitor users' heart rate, detect abnormalities and perform ECG to identify heart problems such as atrial fibrillation.
After Apple introduced the ECG function into Apple Watch, AliveCor, headquartered in Mountain View, California, stopped selling KardiaBand in 2018. AliveCor filed an application with the United States International Trade Commission last year, believing that Apple has copied its technology since the Apple Watch Series 4, and drove AliveCor out of the market by making WearOS incompatible with KardiaBand.
Apple Watch Series 4 through Series 8 have ECG technology. On December 6, 2022, at the request of Apple, the Patent Trial and Appeal Board of the United States Patent and Trademark Office declared the AliveCor patent invalid in the relevant case. The technology giant also filed a counterclaim in the San Francisco Federal Court on the grounds of suspected infringement of its patent.